Topics › Health Sciences › Medicine › Rheumatology
Spondyloarthritis Studies and Treatments Sign in to save
Papers per year
Papers 544
Open in paper search →-
ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update2022 Annals of the Rheumatic Diseases article Medicine Spondyloarthritis Studies and Treatments Open access
Sofía Ramiro, Elena Nikiphorou, Alexandre Rocha Sepriano, Augusta Ortolan, Casper Webers, Xenofon Baraliakos, +27 more
990citations -
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update2020 Annals of the Rheumatic Diseases article Medicine Spondyloarthritis Studies and Treatments Open access
Laure Gossec, Xenofon Baraliakos, Andreas Kerschbaumer, Maarten P. T. de Wit, Iain B. McInnes, Maxime Dougados, +21 more
948citations -
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update2024 Annals of the Rheumatic Diseases article Medicine Spondyloarthritis Studies and Treatments Open access cited by 2 patents
Laure Gossec, Andreas Kerschbaumer, Ricardo J O Ferreira, Daniel Aletaha, Xenofon Baraliakos, Heidi Bertheussen, +30 more
380citations -
Guselkumab in biologic-naive patients with active psoriatic arthritis (DISCOVER-2): a double-blind, randomised, placebo-controlled phase 3 trial2020 The Lancet article Medicine Spondyloarthritis Studies and Treatments Open access cited by 2 patents
Philip J. Mease, Proton Rahman, Alice Bendix Gottlieb, Alexa P. Kollmeier, Elizabeth C. Hsia, Xie Lillian Xu, +5 more
359citations -
Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study2021 Annals of the Rheumatic Diseases article Medicine Spondyloarthritis Studies and Treatments Open access
Atul A. Deodhar, Paula Śliwińska-Stańczyk, Huji Xu, Xenofon Baraliakos, Lianne S. Gensler, Dona L. Fleishaker, +8 more
260citations -
Efficacy and safety of selective TYK2 inhibitor, deucravacitinib, in a phase II trial in psoriatic arthritis2022 Annals of the Rheumatic Diseases article Medicine Spondyloarthritis Studies and Treatments Open access cited by 1 patent
Philip J. Mease, Atul A. Deodhar, Désirée M F M van der Heijde, Frank Behrens, Alan Kivitz, Jeffrey Neal, +4 more
215citations -
Pharmacological treatment of psoriatic arthritis: a systematic literature research for the 2019 update of the EULAR recommendations for the management of psoriatic arthritis2020 Annals of the Rheumatic Diseases article Medicine Spondyloarthritis Studies and Treatments Open access
Andreas Kerschbaumer, Josef S Smolen, Maxime Dougados, Maarten P. T. de Wit, Jette Primdahl, Iain B. McInnes, +4 more
176citations -
Prevalence and distribution of peripheral musculoskeletal manifestations in spondyloarthritis including psoriatic arthritis: results of the worldwide, cross-sectional ASAS-PerSpA study
Clementina López‐Medina, Anna Moltó, Joachim Sieper, Mehmet Tuncay Duruöz, Uta Kiltz, Bassel Kamal Elzorkany, +23 more
144citations -
Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis (SELECT-AXIS 2): a randomised, double-blind, placebo-controlled, phase 3 trial
Atul A. Deodhar, Filip E Van den Bosch, Denis Poddubnyy, Walter P. Maksymowych, Désirée M F M van der Heijde, Tae‐Hwan Kim, +7 more
142citations -
Dual neutralisation of interleukin-17A and interleukin-17F with bimekizumab in patients with active ankylosing spondylitis: results from a 48-week phase IIb, randomised, double-blind, placebo-controlled, dose-ranging study2020 Annals of the Rheumatic Diseases article Medicine Spondyloarthritis Studies and Treatments Open access cited by 1 patent
Désirée M F M van der Heijde, Lianne S. Gensler, Atul A. Deodhar, Xenofon Baraliakos, Denis Poddubnyy, Alan Kivitz, +6 more
134citations -
EULAR points to consider for the definition of clinical and imaging features suspicious for progression from psoriasis to psoriatic arthritis2023 Annals of the Rheumatic Diseases article Medicine Spondyloarthritis Studies and Treatments Open access
Alen Zabotti, Gabriele De Marco, Laure Gossec, Xenofon Baraliakos, Daniel Aletaha, Annamaria Iagnocco, +23 more
134citations -
Efficacy and safety of upadacitinib for active ankylosing spondylitis refractory to biological therapy: a double-blind, randomised, placebo-controlled phase 3 trial2022 Annals of the Rheumatic Diseases article Medicine Spondyloarthritis Studies and Treatments Open access
Désirée M F M van der Heijde, Xenofon Baraliakos, Joachim Sieper, Atul A. Deodhar, Robert Davies Inman, Hideto Kameda, +6 more
129citations -
Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trials2023 Annals of the Rheumatic Diseases article Medicine Spondyloarthritis Studies and Treatments Open access
Désirée M F M van der Heijde, Atul A. Deodhar, Xenofon Baraliakos, Matthew Brown, Hiroaki Dobashi, Maxime Dougados, +18 more
120citations -
Goodbye to the term ‘ankylosing spondylitis’, hello ‘axial spondyloarthritis’: time to embrace the ASAS-defined nomenclature2023 Annals of the Rheumatic Diseases article Medicine Spondyloarthritis Studies and Treatments Open access
Désirée M F M van der Heijde, Anna Moltó, Sofía Ramiro, Jürgen Braun, Maxime Dougados, Floris A van Gaalen, +17 more
118citations -
Efficacy and safety of biological DMARDs: a systematic literature review informing the 2022 update of the ASAS-EULAR recommendations for the management of axial spondyloarthritis2022 Annals of the Rheumatic Diseases review Medicine Spondyloarthritis Studies and Treatments Open access
Casper Webers, Augusta Ortolan, Alexandre Rocha Sepriano, Louise Falzon, Xenofon Baraliakos, Robert Landewé, +3 more
116citations -
The ASAS-OMERACT core domain set for axial spondyloarthritis2021 Seminars in Arthritis and Rheumatism article Medicine Spondyloarthritis Studies and Treatments Open access
Victoria Navarro‐Compán, Anne Boel, Annelies E. R. C. H. Boonen, Philip J. Mease, Robert Landewé, Uta Kiltz, +23 more
106citations -
Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial2021 Annals of the Rheumatic Diseases article Medicine Spondyloarthritis Studies and Treatments Open access
Anna Moltó, Clementina López‐Medina, Filip E Van den Bosch, Annelies E. R. C. H. Boonen, Casper Webers, Emanuelle Dernis, +17 more
104citations -
Long‐Term Efficacy and Safety of Guselkumab, a Monoclonal Antibody Specific to the p19 Subunit of Interleukin‐23, Through Two Years: Results From a Phase III , Randomized, Double‐Blind , Placebo‐Controlled Study Conducted in Biologic‐Naive Patients With Active Psoriatic Arthritis2021 Arthritis & Rheumatology article Medicine Spondyloarthritis Studies and Treatments Open access cited by 1 patent
Iain B. McInnes, Proton Rahman, Alice Bendix Gottlieb, Elizabeth C. Hsia, Alexa P. Kollmeier, Xie Lillian Xu, +6 more
104citations
Most active Aachen authors
-
Désirée M F M van der Heijde 125,866 citations overall246 papers
-
Sofía Ramiro 18,788 citations overall201 papers
-
Floris A van Gaalen 8,909 citations overall103 papers
-
Alexandre Rocha Sepriano 10,345 citations overall49 papers
-
M. Reijnierse 7,517 citations overall47 papers
-
M. van Lunteren 800 citations overall43 papers
-
Désirée van der Heijde 10,239 citations overall32 papers
-
D. van der Heijde 2,231 citations overall26 papers
-
Mary Lucy Marques 242 citations overall25 papers
-
S. Ramiro 105 citations overall21 papers
-
Salima F. E. van Weely 812 citations overall20 papers
-
T. P. M. Vliet Vlieland 18,151 citations overall18 papers
-
Paul Bergmans 2,887 citations overall15 papers
-
Augusta Ortolan 3,145 citations overall14 papers
-
Anne Boel 587 citations overall14 papers